Piet H van der Graaf
Overview
Explore the profile of Piet H van der Graaf including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
167
Citations
1713
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shim J, Rehberg M, Wagenhuber B, van der Graaf P, Chung D
Front Pharmacol
. 2025 Mar;
16:1479666.
PMID: 40070575
Disease activity scores are efficacy endpoints in clinical trials of inflammatory bowel disease (IBD) therapies. Crohn's disease activity index (CDAI), Mayo endoscopic score (MES) and Mayo score are frequently used...
2.
Zhao L, van der Graaf P
Clin Pharmacol Ther
. 2025 Feb;
117(3):609-611.
PMID: 39965182
No abstract available.
3.
Vicini P, van der Graaf P
Handb Exp Pharmacol
. 2025 Jan;
PMID: 39836221
The application of quantitative systems pharmacology (QSP) has enabled substantial progress and impact in many areas of therapeutic discovery and development. This new technology is increasingly accepted by industry, academia,...
4.
5.
Kaddi C, Tao M, Bergeler S, George K, Geerts H, van der Graaf P, et al.
Clin Pharmacol Ther
. 2024 Dec;
117(2):579-588.
PMID: 39632463
Pompe disease is a rare, progressive neuromuscular disease caused by deficient lysosomal glycogen degradation, and includes both late-onset (LOPD) and severe infantile-onset (IOPD) phenotypes. Due to very small patient numbers...
6.
Ramamoorthy A, Younis I, Wen Y, Mehanna M, Giacomini K, van der Graaf P
Clin Pharmacol Ther
. 2024 Nov;
116(6):1363-1368.
PMID: 39543918
No abstract available.
7.
van den Maagdenberg H, Sicho M, Araripe D, Luukkonen S, Schoenmaker L, Jespers M, et al.
J Cheminform
. 2024 Nov;
16(1):128.
PMID: 39543652
Building reliable and robust quantitative structure-property relationship (QSPR) models is a challenging task. First, the experimental data needs to be obtained, analyzed and curated. Second, the number of available methods...
8.
Giacomini K, van der Graaf P
Clin Pharmacol Ther
. 2024 Oct;
116(4):885-889.
PMID: 39363446
No abstract available.
9.
Carretero-Iglesia L, Hall O, Berret J, Pais D, Estoppey C, Chimen M, et al.
Nat Cancer
. 2024 Sep;
5(10):1494-1514.
PMID: 39261676
Despite recent advances in immunotherapies targeting single tumor-associated antigens, patients with multiple myeloma eventually relapse. ISB 2001 is a CD3 T cell engager (TCE) co-targeting BCMA and CD38 designed to...
10.
Minichmayr I, Shebley M, van der Graaf P, Venkatakrishnan K
Clin Pharmacol Ther
. 2024 Aug;
116(3):491-496.
PMID: 39164848
No abstract available.